NDC 19515-897

Flulaval Quadrivalent 2019/2020

Influenza Virus Vaccine

Flulaval Quadrivalent 2019/2020 is a Intramuscular Suspension in the Vaccine category. It is labeled and distributed by Id Biomedical Corporation Of Quebec. The primary component is Influenza A Virus A/brisbane/02/2018 Ivr-190 (h1n1) Antigen (uv, Formaldehyde Inactivated); Influenza A Virus A/kansas/14/2017 X-327 (h3n2) Antigen (uv, Formaldehyde Inactivated); Influenza B Virus B/phuket/3073/2013 Antigen (uv, Formaldehyde Inactivated); Influenza B Virus B/maryland/15/2016 Bx-69a Antigen (uv, Formaldehyde Inactivated).

Product ID19515-897_2a9a9563-8797-4c1f-acbf-d2c4ef974e87
NDC19515-897
Product TypeVaccine
Proprietary NameFlulaval Quadrivalent 2019/2020
Generic NameInfluenza Virus Vaccine
Dosage FormSuspension
Route of AdministrationINTRAMUSCULAR
Marketing Start Date2019-07-02
Marketing End Date2020-06-30
Marketing CategoryBLA / BLA
Application NumberBLA125163
Labeler NameID Biomedical Corporation of Quebec
Substance NameINFLUENZA A VIRUS A/BRISBANE/02/2018 IVR-190 (H1N1) ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/KANSAS/14/2017 X-327 (H3N2) ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/MARYLAND/15/2016 BX-69A ANTIGEN (UV, FORMALDEHYDE INACTIVATED)
Active Ingredient Strength15 ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL
NDC Exclude FlagN

Packaging

NDC 19515-897-11

1 VIAL, MULTI-DOSE in 1 CARTON (19515-897-11) > 5 mL in 1 VIAL, MULTI-DOSE (19515-897-01)
Marketing Start Date2019-07-02
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 19515-897-01 [19515089701]

Flulaval Quadrivalent 2019/2020 SUSPENSION
Marketing CategoryBLA
Application NumberBLA125163
Product TypeVACCINE
Billing UnitML
Marketing Start Date2019-07-02
Marketing End Date2020-06-30

NDC 19515-897-11 [19515089711]

Flulaval Quadrivalent 2019/2020 SUSPENSION
Marketing CategoryBLA
Application NumberBLA125163
Product TypeVACCINE
Billing UnitML
Marketing Start Date2019-07-02
Marketing End Date2020-06-30

Drug Details

Active Ingredients

IngredientStrength
INFLUENZA A VIRUS A/BRISBANE/02/2018 IVR-190 (H1N1) ANTIGEN (UV, FORMALDEHYDE INACTIVATED)15 ug/.5mL

NDC Crossover Matching brand name "Flulaval Quadrivalent 2019/2020" or generic name "Influenza Virus Vaccine"

NDCBrand NameGeneric Name
58160-885FLUARIX QUADRIVALENTinfluenza virus vaccine
58160-887FLUARIX QUADRIVALENTinfluenza virus vaccine
58160-890FLUARIX QUADRIVALENTinfluenza virus vaccine
58160-896FLUARIX QUADRIVALENTinfluenza virus vaccine
58160-898FLUARIX QUADRIVALENTinfluenza virus vaccine
19515-808Flulaval Quadrivalentinfluenza virus vaccine
19515-816Flulaval Quadrivalentinfluenza virus vaccine
19515-818Flulaval Quadrivalentinfluenza virus vaccine
19515-897Flulaval Quadrivalentinfluenza virus vaccine
19515-900Flulaval Quadrivalentinfluenza virus vaccine
19515-906Flulaval Quadrivalentinfluenza virus vaccine
19515-909Flulaval Quadrivalentinfluenza virus vaccine

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.